Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | GRM5 | P41594 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 4/20 | 0.50 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.49 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | TNF | P01375 | 1/20 | 0.46 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3713895 | 1.00 | TDP1 (0.57) | TDP1GRM5HTTCYP11B1CYP11B2 | |
| SCHEMBL5399 | 0.98 | TDP1 (0.59) | TDP1GRM5HTTCYP11B1CYP11B2 | |
| SCHEMBL29359161 | 0.98 | TDP1 (0.59) | TDP1GRM5HTTCYP11B1CYP11B2 | |
| SCHEMBL28652434 | 0.95 | TDP1 (0.57) | TDP1GRM5HTTCYP11B1CYP11B2 | |
| Bromide SCHEMBL10432264 | 0.95 | TDP1 (0.57) | TDP1GRM5HTTCYP11B1CYP11B2 | |
| Iodide SCHEMBL15375366 | 0.95 | TDP1 (0.57) | TDP1GRM5HTTCYP11B1CYP11B2 | |
| Bromide SCHEMBL6955674 | 0.95 | TDP1 (0.57) | TDP1GRM5HTTCYP11B1CYP11B2 | |
| Methylamine SCHEMBL28557648 | 0.93 | TDP1 (0.55) | TDP1GRM5HTTCYP11B1CYP11B2 | |
| SCHEMBL30395666 | 0.90 | TDP1 (0.52) | TDP1GRM5HTTCYP11B1CYP11B2 | |
| SCHEMBL15639423 | 0.90 | TDP1 (0.52) | TDP1GRM5HTTCYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115155655-B | Nonmetal liquid phase catalyst, application thereof and method for synthesizing chloroethylene | 厦门中科易工化学科技有限公司 | 2024-08-06 | — | — | CN | claimed |
| CN-115155655-A | Nonmetal liquid phase catalyst, application thereof and method for synthesizing chloroethylene | 厦门中科易工化学科技有限公司 | 2022-10-11 | — | — | CN | claimed |
| EP-3166981-B1 | OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF | DSM NUTRITIONAL PRODUCTS LLC (US) | 2026-05-13 | — | — | EP | disclosed |
| CN-119100907-A | Synthetic method of chloroethylene and polyvinyl chloride | 厦门中科易工化学科技有限公司 | 2024-12-10 | — | — | CN | disclosed |
| EP-3459975-B1 | POLYMERIC ACID CATALYSTS AND USES THEREOF | DSM NUTRITIONAL PRODUCTS LLC (US) | 2024-10-02 | — | — | EP | disclosed |
| CN-115155655-B | Nonmetal liquid phase catalyst, application thereof and method for synthesizing chloroethylene | 厦门中科易工化学科技有限公司 | 2024-08-06 | — | — | CN | disclosed |
| US-11584805-B2 | Oligosaccharide compositions and methods for producing thereof | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2023-02-21 | — | — | US | disclosed |
| CN-115155655-A | Nonmetal liquid phase catalyst, application thereof and method for synthesizing chloroethylene | 厦门中科易工化学科技有限公司 | 2022-10-11 | — | — | CN | disclosed |
| US-11059791-B2 | Non-coordinating anion type benzimidazolium activators | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-07-13 | — | — | US | disclosed |
| US-20210002387-A1 | OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF | HERCULES CAPITAL, INC. | 2021-01-07 | — | — | US | disclosed |
| US-20200339517-A1 | Non-Coordinating Anion Type Benzimidazolium Activators | EXXONMOBIL CHEMICAL PATENTS INC. | 2020-10-29 | — | — | US | disclosed |
| WO-2013163230-A2 | BIO-BASED POLYMERS AND METHODS OF PRODUCING THEREOF | Midori Renewables, Inc. (US) | 2013-10-31 | — | — | WO | disclosed |
| US-20130233308-A1 | POLYMERIC ACID CATALYSTS AND USES THEREOF | Midori Renewables, Inc. (US) | 2013-09-12 | — | — | US | disclosed |
| US-8476388-B2 | Polymeric acid catalysts and uses thereof | Midori Renewables, Inc. (US) | 2013-07-02 | — | — | US | disclosed |
| US-8466242-B2 | Polymeric acid catalysts and uses thereof | Midori Renewables, Inc. (US) | 2013-06-18 | — | — | US | disclosed |
| US-20130042859-A1 | POLYMERIC ACID CATALYSTS AND USES THEREOF | Midori Renewables, Inc. (US) | 2013-02-21 | — | — | US | disclosed |
| US-20120252957-A1 | POLYMERIC ACID CATALYSTS AND USES THEREOF | Midori Renewables, Inc. (US) | 2012-10-04 | — | — | US | disclosed |
| WO-2012118767-A1 | POLYMERIC ACID CATALYSTS AND USES THEREOF | Midori Renewables, Inc. (US) | 2012-09-07 | — | — | WO | disclosed |
| US-20120220740-A1 | POLYMERIC ACID CATALYSTS AND USES THEREOF | Midori Renewables, Inc. (US) | 2012-08-30 | — | — | US | disclosed |
| WO-2003016612-A1 | TEXTILE TREATMENT | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2003-02-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210002387-A1 | OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF | OSTC, FUT5, FUT6 | TDP1 4531/4885GRM5 3677/4885HTT 4163/4885 |
| US-11584805-B2 | Oligosaccharide compositions and methods for producing thereof | OSTC, FUT5, FUT6 | TDP1 4531/4885GRM5 3677/4885HTT 4163/4885 |
| US-20120252957-A1 | POLYMERIC ACID CATALYSTS AND USES THEREOF | MGAM, PGLS, GAA | TDP1 1313/4885GRM5 3835/4885HTT 3885/4885 |
| US-20120220740-A1 | POLYMERIC ACID CATALYSTS AND USES THEREOF | MGAM, PGLS, GAA | TDP1 1343/4885GRM5 3811/4885HTT 3784/4885 |
| US-20200339517-A1 | Non-Coordinating Anion Type Benzimidazolium Activators | VDAC1, MYB, BID | TDP1 2981/4885GRM5 4614/4885HTT 828/4885 |
| US-11059791-B2 | Non-coordinating anion type benzimidazolium activators | VDAC1, MYB, BID | TDP1 2981/4885GRM5 4614/4885HTT 828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.